Demonstrating faster, simpler, more cost-efficient NGS workflows that turn complex agrigenomics data into practical ...
Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...
Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...
CORA Loyalty, the loyalty portfolio arm of CORA Group ("CORA"), advises financial institutions to move beyond product-based rewards and adopt enterprise loyalty strategies that recognize and reward ...
As of Thursday, January 08, Standard BioTools Inc.’s LAB share price has surged by 11.72%, which has investors questioning if ...
Integrated software, AI-driven analytics, and frictionless workflows enable customers to harness the full power of biological ...
Helix, the leading enterprise genomics company, today announced a multi-year strategic collaboration with GSK, the global biopharma company. This agreement provides GSK access to Helix's continuously ...
StockStory.org on MSN
10x Genomics (TXG) stock is up, what you need to know
What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several ...
3don MSN
Cathie Wood's moves entering 2026: bets on gene-editing and genomics names, adds BEAM, TWST, NTLA
Cathie Wood’s latest moves entering 2026 focused on early-stage biotechnology firms while cutting exposure to consumer ...
Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
As of Thursday, January 08, Neogen Corporation’s NEOG share price has surged by 34.28%, which has investors questioning if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results